Stem Cells and Mitochondria: Probing MT-ATP6 mutations using iPSC-derived neural cells

Carmen Lorenz is researcher at Max Delbrueck Center for Molecular Medicine (MDC) in Berlin, Germany.

During Targeting Mitochondria World Congress, she will present her recent studies about "Probing MT-ATP6 mutations using iPSC-derived neural cells".

Volkmar Weissig and Marvin Edeas asked to Carmen Lorenz to highlight the following strategic points:

• Are iPSC-derrived neural cells a good model system for mitochondrial diseases?
• Can we find treatments for mitochondrial diseases?
• Can we detect a disease phenotype of mitochondrial neurological disorders in a dish?

Marvin Edeas stated: "Targeting Mitochondria and stem cells is one of the hot topics that we will largely discuss during Targeting Mitochondria 2016".

Marvin Edeas / Volkmar Weissig / Chairmen of WMS
www.targeting-mitochondria.com